Research Article
The Effectiveness of Cancer Pain Management in a Tertiary Hospital Outpatient Pain Clinic in Thailand: A Prospective Observational Study
Table 1
Baseline demographic data.
| | | n = 150 |
| | Age (years), median (IQR) | 58.0 (50.0–66.0) | | Gender, n (%) | | | Male | 85 (56.7) | | Female | 65 (43.3) | | BMI, median (IQR) | 20.7 (18.4–23.3) | | Status, n (%) | | | Married | 105 (70.0) | | Single/divorced/widowed | 45 (30.0) | | Living with, n (%) | | | Family/sibling | 143 (95.3) | | Alone | 7 (4.7) | | Education, n (%) | | | High school and below | 94 (62.7) | | Higher than high school | 56 (37.3) | | Pain score (NRS), median (IQR) | 5.0 (4.0–6.0) | | Karnofsky performance status (%), median (IQR) | 70.0 (60.0–80.0) | | Cancer status, n (%) | | | Local | 29 (19.3) | | Advanced | 121 (80.7) | | Primary tumor, n (%) | | | Gastrointestinal | 40 (26.7) | | Bronchus and lung | 19 (12.7) | | Breast | 9 (6.0) | | Head and neck | 40 (26.7) | | Hematological | 4 (2.7) | | Gynecological | 22 (14.7) | | Urological | 12 (8.0) | | Musculoskeletal | 4 (2.7) | | Pain medications taken, n (%) | | | Opioids | 128 (85.3) | | Acetaminophen | 70 (46.7) | | NSAIDs | 14 (9.3) | | Anticonvulsants | 57 (38.0) | | Antidepressants | 21 (14.0) | | Laxatives | 53 (35.3) | | Antiemetics | 10 (6.7) | | MEDD prescription (mg/day), median (IQR) | 50.0 (15.0–82.0) | | MEDD taken (mg/day), median (IQR) | 20.0 (10.0–31.0) | | History of radiation before study, n (%) | 48 (32.0) | | Duration (days) from diagnosis, median (IQR) | 296.0 (76.0–855.0) |
|
|
BMI: Body Mass Index; NRS: Numerical Rating Scale; NSAIDs: Nonsteroidal Anti-Inflammatory Drugs; MEDD: Morphine Equivalent Diary Dosage.
|
